Single-Cell Regulatory Network Analysis Identifies Adjunctive Drug Candidates in Early Risankizumab-Treated Psoriasis

Authors

Institutions

Publication Details

Journal
Current Pharmaceutical Design
Published
2026-01-14
DOI
https://doi.org/10.2174/0113816128415490251122070946
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single-Cell Regulatory Network Analysis Identifies Adjunctive Drug Candidates in Early Risankizumab-Treated Psoriasis

Xue Zhang, Denghai Zhang, Yupeng Ma, Shumin Zhang et al.
Current Pharmaceutical Design
Psoriasis: Treatment and Pathogenesis
article

Single-Cell Regulatory Network Analysis Identifies Adjunctive Drug Candidates in Early Risankizumab-Treated Psoriasis

Xue Zhang, Denghai Zhang, Yupeng Ma, Shumin Zhang, Xinhong Chen
article en

Abstract

No abstract available for this paper.
Current Pharmaceutical DesignVol. 32
University of Shanghai for Science and Technology (CN), Second Military Medical University (CN), Ningxia Medical University (CN), Shanghai Pudong New Area Gongli Hospital (CN)
Good health and well-being
Openalex Percentile: Top 79%
Psoriasis: Treatment and Pathogenesis
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.